Analyst Information for Sarepta Therapeutics Inc.

$ 106.17   0.42 (+0.40%) Volume: 1.08m 4:00 PM EST 10-Dec-2019
After Hours:  $ 106.17 0.00 (0.00%) Volume: 13.43k 5:06 PM EST 10-Dec-2019
Consensus Rating Average
Consensus Rating for SRPT is STRONG BUY
Since many brokers have different rating systems, we maintain a standard system with an assigned numeric value from 1 to 5. Ratings are a translation of brokers' recommendations to the recommendation scale, which ranges from a rating of 1 (a strong buy) to a rating of 5 (a strong sell).
Rating Scale
Strong Buy 1.0 - 1.5
Moderate Buy 1.6 - 2.5
Hold 2.6 - 3.5
Moderate Sell 3.6 - 4.5
Strong Sell 4.6 - 5.0
Consensus Rating Details
Current Average Recommendation 1.22
Previous Average Recommendation 1.22
Change in Average Recommendation 0.00
Number of Analysts Reporting 16
Strong Buy
1.0
Current: 1.22
Previous: 1.22
Change: 0.00
Strong Sell
5.0
Consensus Rating Industry Comparison
Industry: MED-BIOMED/GENE
Number of companies in industry with recommendations 387
Rank Recommendation relative to companies in its industry 226
Ranked 226 in Industry
1387 MED-BIOMED/GENE
Analyst Recommendations
Analysts recommending Strong Buy 13
Analysts recommending Moderate Buy 2
Analysts recommending Hold 1
Analysts recommending Moderate Sell 0
Analysts recommending Strong Sell 0
Vertical Bar Chart
Recommendations History
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 13 13 13 13
Moderate Buy 2 2 2 3
Hold 1 1 1 1
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.22 1.22 1.22 1.26

Copyright © QuoteMedia.   Data delayed at least 15 min. unless otherwise indicated.    RT = Real-Time,  EOD = End Of Day,  PD = Previous Day.   Market Data powered by QuoteMedia. Analyst ratings by Zacks.   Terms of Use.